Why Europe Has Access to More Sunscreen Filters Than the U.S.

Why Two Sunscreen Markets Evolved Differently 

Walk into a pharmacy in Paris and then walk into one in New York, and the sunscreen aisle may look surprisingly different. 

The SPF numbers may be similar. The packaging may make similar claims. Both products are designed to protect against ultraviolet radiation. Yet many consumers, formulators, and dermatologists have long noted that European sunscreens often feel different. They are frequently described as lighter, more fluid, easier to spread, and better suited for high-SPF daily wear. 

The difference is not simply a matter of formulation preference. It is rooted in the sunscreen filters available to formulators. 

Over the last two decades, Europe and the United States have followed different regulatory paths for sunscreen filters. While both regions aim to ensure product safety and efficacy, the approval systems governing sunscreen ingredients evolved differently. As a result, formulators in Europe gained access to a broader portfolio of sunscreen filters, including several newer-generation UV filters that were unavailable in the United States for many years. 

That difference shaped how sunscreen products were designed, how broad-spectrum protection was achieved, and how innovation progressed across the two markets. 

Today, the conversation is becoming even more relevant as the FDA moves toward approving newer sunscreen filters such as bemotrizinol (BEMT), a step many industry observers view as a significant milestone in modernizing the U.S. sunscreen landscape. 

Sunscreens Are Regulated Differently in the U.S. and Europe 

To understand why sunscreen filters differ between markets, it is important to understand how sunscreens are regulated. 

In the United States, sunscreens are regulated as over-the-counter drugs. Sunscreen filters are treated as active ingredients, which means new filters must pass through a regulatory framework designed for drug products. This process emphasizes extensive safety and efficacy evaluation before a new active ingredient can enter the market. 

In Europe, sunscreens are regulated as cosmetic products. UV filters are regulated under Annex VI of the European Cosmetics Regulation, which establishes a list of approved sunscreen filters and their permitted concentrations. While safety evaluation remains rigorous, the regulatory pathway differs from the OTC drug framework used in the United States. 

These regulatory differences created two very different innovation environments. 

The European system enabled the approval of several newer-generation sunscreen filters over the last two decades, while the U.S. market continued to rely largely on filters that had already been included in the FDA sunscreen monograph. 

The result was not simply a difference in ingredient lists. It became a difference in formulation possibilities. 

Why Europe Approved More Sunscreen Filters 

The sunscreen filter gap did not emerge overnight. 

Many of the sunscreen filters commonly used in Europe today were developed to address specific formulation challenges. Some were designed to improve UVA protection. Others were developed to increase photostability, reduce formulation complexity, or improve broad-spectrum coverage. 

A peer-reviewed review comparing ultraviolet filters in the United States and European Union highlighted that Europe has access to a larger number of approved sunscreen filters than the U.S. market. While exact figures vary depending on regulatory updates, the difference has remained substantial for years. 

This expanded filter portfolio gave European formulators more flexibility when designing sunscreen systems. 

Instead of relying on a smaller number of approved filters to achieve broad-spectrum protection, formulators could distribute UV coverage across a wider range of ingredients with different absorption profiles and performance characteristics. 

This flexibility becomes particularly important when creating high-SPF products that also need to maintain cosmetic elegance.

The Sunscreen Filters That Changed European Formulation 

Several sunscreen filters became especially influential in European sunscreen development. 

One of the most discussed examples is bemotrizinol, often referred to as BEMT. Bemotrizinol is a broad-spectrum UV filter capable of absorbing both UVA and UVB radiation. It is widely recognized for its photostability, meaning it remains effective during UV exposure without significant degradation. 

Another important filter is bisoctrizole, which also provides broad-spectrum protection and is frequently used in modern European sunscreen systems. 

Additional filters such as Uvinul A Plus and Uvinul T 150 expanded formulation possibilities by allowing formulators to target specific portions of the UV spectrum more efficiently. 

The significance of these sunscreen filters extends beyond simple UV absorption. 

They changed how formulators approached sunscreen architecture. 

Instead of depending heavily on a limited group of filters to achieve broad-spectrum coverage, formulators gained access to specialized tools that could contribute UVA protection, UVB efficiency, photostability, or overall formulation optimization. 

As more filters became available, sunscreen systems became increasingly sophisticated. 

How Sunscreen Filters Influence Formulation Possibilities 

The availability of sunscreen filters influences far more than SPF values. 

Every sunscreen formulation is a balancing act involving: 

• UV protection 

• stability 

• transparency 

• texture 

• spreadability 

• wearability 

• compatibility with other ingredients 

The more options formulators have, the more precisely they can balance those variables. 

Imagine attempting to solve a complex engineering problem using only a handful of available tools. It can be done, but flexibility becomes limited. 

That is essentially the challenge many formulators faced in the U.S. market. 

A broader portfolio of sunscreen filters allows formulators to distribute UV protection more strategically. Some filters contribute strongly to UVA protection. Others provide UVB efficiency. Some improve photostability. Others help reduce formulation burden by increasing overall protection efficiency. 

This flexibility can influence everything from SPF performance to sensory experience. 

The result is not necessarily a stronger sunscreen. It is often a more adaptable sunscreen design process. 

Why European Sunscreens Often Feel Different 

The difference many consumers notice between European and U.S. sunscreens is often linked to formulation flexibility rather than sunscreen effectiveness alone. 

High-SPF products require substantial UV protection capacity. When formulators have access to a broader range of sunscreen filters, they can distribute that protection across multiple ingredients instead of relying heavily on a smaller number of approved filters. 

This can influence texture, spreadability, transparency, and overall product aesthetics. 

European markets became particularly active in developing lightweight sunscreen fluids, daily-wear sunscreen systems, and high-protection formulations designed for comfortable everyday use. 

The availability of newer sunscreen filters did not automatically create better textures. However, it expanded the formulation toolbox available to product developers. 

That additional flexibility helped support innovation in product formats that combined high SPF values with lighter sensory profiles. 

This is one reason discussions about sunscreen innovation often focus not only on SPF numbers, but also on the sunscreen filters available to formulators. 

The BEMT Factor and Regulatory Modernization 

The conversation around sunscreen filters changed significantly when the FDA proposed adding bemotrizinol to the U.S. sunscreen monograph. 

For years, BEMT was one of the most frequently cited examples when discussing the difference between U.S. and European sunscreen filter availability. 

The FDA’s proposed order recognizes bemotrizinol as a broad-spectrum sunscreen active ingredient and proposes allowing its use at concentrations up to 6% under specified conditions. 

This development is important because it signals movement toward expanding the range of sunscreen filters available within the U.S. regulatory framework. 

BEMT itself is not a complete solution to every sunscreen formulation challenge. However, its approval would represent a broader shift toward regulatory modernization and could open the door for future discussions around additional sunscreen filters. 

The significance of BEMT extends beyond one ingredient. 

It represents a larger conversation about innovation, public health, formulation flexibility, and access to newer sunscreen technologies. 

Is the U.S. Beginning to Catch Up? 

The sunscreen filter gap between Europe and the United States is still present, but the conversation is changing. 

Growing attention from dermatologists, researchers, formulators, and public health organizations has increased discussion around modernizing sunscreen regulations and expanding access to newer sunscreen filters. 

Recent scientific publications have argued that allowing evidence-supported sunscreen filters already used internationally could improve sunscreen options available to consumers. 

At the same time, regulators must balance innovation with safety evaluation, which remains a central objective of sunscreen regulation. 

This means change is likely to be gradual rather than immediate. 

However, the direction of the discussion is increasingly focused on how newer sunscreen filters can support broader public health goals while maintaining rigorous safety standards.

What It Means for Future Sunscreen Innovation 

The story of sunscreen filters is ultimately a story about innovation. 

For decades, Europe and the United States operated under different regulatory frameworks that produced different ingredient landscapes. Those differences influenced how sunscreen products were formulated, how broad-spectrum protection was achieved, and how innovation evolved across the two markets. 

The debate is not about determining which market is better. 

It is about understanding how regulatory systems influence the tools available to formulators. 

As newer sunscreen filters continue to be evaluated and regulatory frameworks evolve, the gap between the two markets may gradually narrow. 

For formulators, access to a broader range of sunscreen filters creates more opportunities to balance protection, photostability, transparency, and sensory performance. 

For consumers, it may eventually mean greater access to sunscreen products designed around a wider spectrum of formulation possibilities. 

The future of sunscreen innovation will not be defined by a single ingredient. It will be shaped by how effectively regulatory science, safety evaluation, and formulation technology continue to evolve together.

__________________________________________________________________________________________________________ 

Frequently Asked Questions (FAQs)

Why does Europe have more sunscreen filters than the U.S.?

Europe and the United States regulate sunscreens differently. In Europe, sunscreens are regulated as cosmetic products, while in the U.S. they are regulated as over-the-counter drugs. These different regulatory pathways have influenced how quickly new sunscreen filters become available in each market. 

What are sunscreen filters? 

Sunscreen filters are active ingredients that help protect the skin from ultraviolet radiation. Different sunscreen filters absorb, scatter, or attenuate UV radiation across various parts of the UV spectrum, helping formulators create broad-spectrum sunscreen products. 

Are European sunscreens better than U.S. sunscreens? 

Not necessarily. Both markets offer effective sunscreen products that meet their respective regulatory requirements. The main difference is that European formulators have historically had access to a broader range of sunscreen filters, which can provide additional formulation flexibility. 

Why do some European sunscreens feel lighter on the skin? 

One reason is the wider range of sunscreen filters available to European formulators. A broader filter portfolio can make it easier to distribute UV protection across multiple ingredients, helping formulators optimize texture, spreadability, and overall sensory performance. 

What is bemotrizinol (BEMT)? 

Bemotrizinol, commonly known as BEMT, is a broad-spectrum sunscreen filter that provides both UVA and UVB protection. It is widely used in many international sunscreen markets and has become a major topic in discussions about sunscreen innovation and regulatory modernization in the United States. 

Is the sunscreen filter gap between Europe and the U.S. changing? 

Yes. Recent regulatory developments, including the FDA’s proposal regarding bemotrizinol, suggest that discussions around modernizing sunscreen filters in the U.S. are gaining momentum. While the gap still exists, future regulatory changes may gradually expand the sunscreen filters available to U.S. formulators.